112576 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving isomerase
CELL-FREE METHOD OF PRODUCING SYNTHETIC CIRCULAR NUCLEIC ACID
#2USE OF PGAM2 IN BREEDING OF BLCATTLE BLACK CATTLE
#3METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY
#4BIO-ENGINEERED ENZYMES AND USES THEREOF
#5CELL-FREE METHOD OF PRODUCING SYNTHETIC CIRCULAR NUCLEIC ACID
#6METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#7DGAT1/2-INDEPENDENT ENZYME SYNTHESIZING STORAGE LIPIDS (DIESL)
#8DETECTION OF ANALYTE
#9NANOSCALE MOTION DETECTOR
#10T5 exonuclease-based method to identify DNA topoisomerase inhibitors
#11T5 exonuclease-based method to identify DNA topoisomerase inhibitors
#12DESIGNING CUSTOMIZED PROTEIN-SPECIFIC-BUFFER SYSTEM
#13METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#14METHODS OF INHIBITING PROLIFERATIVE CELLS
#15SYSTEMS AND METHODS FOR ENGINEERING ENZYMES
#16Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
#17METHODS FOR DIAGNOSING AND ASSESSING TREATMENT FOR CUSHING'S SYNDROME
#18Nanoscale motion detector
#19Materials and methods for identifying gyrase inhibitors
#20Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
#21Methods for diagnosing and assessing treatment for Cushing's syndrome
#22Designing customized protein-specific buffer system
#23Methods and reagents for analyzing protein-protein interfaces
#24Methods and reagents for analyzing protein-protein interfaces
#25Methods and composition for modifying enzymes
#26RUBBER-LIKE MATERIAL FOR THE IMMOBILIZATION OF PROTEINS AND ITS USE IN LIGHTING, DIAGNOSIS AND BIOCATALYSIS
#27Prostate cancer-associated secreted proteins
#28Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
#29Methods for treating Cushing's syndrome
#30System and method for detecting alpha-methylacyl-CoA racemase (AMACR) and prostate cancer
#31Method for evaluating condition of skin dryness
#32METHODS OF IDENTIFYING ENZYMES AND MICROORGANISMS
#33ENHANCED ATRA-RELATED COMPOUNDS DERIVED FROM STRUCTURE-ACTIVITY RELATIONSHIPS AND MODELING FOR INHIBITING PIN1
#34Methods and reagents for analyzing protein-protein interfaces
#35Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
#36System and method for detecting of alpha-methylacyl-CoA racemase (AMACR) and prostate cancer
#37Method of screening anti-plasmodial activity of acriflavin and acriflavin as an anti-malarial agent
#38Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase
#39NANOSCALE MOTION DETECTOR
#40Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity
#41Isomerases, nucleic acids encoding them and methods for making and using them
#42METHOD OF ASSAYING DNA TOPOISOMERASES AND DNA BINDING PROTEINS USING HIGH THROUGHPUT SCREENING
#43INHIBITION OF ANTIMICROBIAL TARGETS WITH REDUCED POTENTIAL FOR RESISTANCE
#44Oxidosqualene cyclase as a protein target for anticancer therapeutics
#45Methods and compositions for topoisomerase I modulated tumor suppression
#46TOP2A inhibition by temozolomide and its predictive value of GBM patients survival
#47BIOMARKERS
#48Novel tumor marker determination
#49Topoisomerase binding probe and method of use
#50IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE
#51Quantitative helicase assay
#52Sensor chip for screening topoisomerase inhibitor and screening method thereof
#53TREATING CANCER BY MODULATING RNA HELICASES
#54Microfluidic device screening method
#55Methods and compositions for topoisomerase I modulated tumor suppression
#56DIAGNOSIS OF SYSTEMIC DISEASES
#57Compositions and Methods for Spatial Separation and Screening of Cells
#58Isomerases, nucleic acids encoding them and methods for making and using them
#59Method for preparing a measurement sample for detecting live cells of a microorganism in a test sample
#60Method for detection of microorganism and kit for detection of microorganism
#61METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8
#62IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE
#63Administration of agents mimicking dopachrome tautomerase (TRP-2) activity for protecting hair follicle melanocytes
#64Molecular accessibility assay
#65DETERMINATION OF CHANGES IN CONCENTRATION
#66Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#67Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin D synthase
#68Method for Identifying Fungicidally Active Compounds that are Based on Ipp Isomerases
#69Relaxase Modulators and Methods of Using Same
#70Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition
#71Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#72Assay for determination of free D-galactose and/or L-arabinose
#73Method for detection of microorganism and kit for detection of microorganism
#74Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors
#75Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
#76Pin1-modulating compounds and methods of use thereof
#77Identification and screening of triptolide target molecules
#78Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases
#79Method for diagnosing non-small cell lung cancers by tRNA-dihydrouridine synthase activity of
#80Polynucleotide Sequencing Using a Helicase
#81Assays for identification of topoisomerase inhibitors
#82Methods and compositions for treating and preventing neurologic disorders
#83NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY NKG2D-POSITIVE CD4+ CELLS
#84Method for Identifying and Producing Effectors of Calmodulin-Dependent Peptidyl-Prolyl Cis/Trans Isomers
#85Novel antibacterial agents
#86Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#87Methods and means for inhibiting fever
#88Methods of screening bifunctional molecules for modulated pharmacokinetic properties
#89Method for predicting pregnancy-induced hypertension
#90Eukaryotic genes involved in adult lifespan regulation
#91Method for the microbiological isomerisation of alpha-hydroxy carboxylic acids
#92Method of screening for agents that modulate a homer signaling pathway
#93Enzyme cycling based assays for alpha-methylacyl-CoA racemase
#94Enzyme cycling based assays for alpha-methylacyl-CoA racemase
#95Protein markers for pharmaceuticals and related toxicity
#96Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#97Crystallographic structure of TcPRACA and uses therefor
#98Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
#99Stratification of patient populations having or suspected of having rheumatoid arthritis
#100Administration of agents mimicking DOPAchrome tautomerase (TRP-2) activity for protecting hair follicle melanocytes
#101Therapeutic and diagnostic applications of protein disulphide isomerases
#102Dectection of AMACR cancer markers in urine
#103High-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity
#104Method and composition for determining resistance to an acetohydroxy-acid synthase inhibitor
#105Method for detecting catalytic activity
#106High throughput screening assay to identify DNA topoisomerase inhibitors
#107T5 exonuclease-based method to identify DNA topoisomerase inhibitors